retatrutide clinical trial dosing frequency Schedule for Retatrutide: Data, Safety and UK Status – Bolt Pharmacy Retatrutide Starting Dose | Everest

doi:10.3945/ajcn.2010.29885

However, appropriate use extends beyond FDA label indications

Longo M, et al

Wondering whether a GLP-1 would be a good option for you

And leading that charge

The current generation of GLP-1 receptor agonists includes: Semaglutide (weekly subcutaneous injection or oral formulation) Liraglutide (daily subcutaneous injection) Tirzepatide (dual GLP-1/GIP receptor agonist, weekly subcutaneous injection) Each of these GLP-1 agents carries a distinct pharmacological profile, and the optimal choice depends on a patients clinical history, metabolic risk factors, and therapeutic goals a determination best made in consultation with a physician experienced in metabolic and longevity medicine